Symbol="CYTK"
AssetType="Common Stock"
Name="Cytokinetics Inc"
Description="Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California."
CIK="1061983"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="280 EAST GRAND AVENUE, ., SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3340726000"
EBITDA="-364496992"
PERatio="None"
PEGRatio="-0.42"
BookValue="-2.395"
DividendPerShare="0"
DividendYield="0"
EPS="-4.59"
RevenuePerShareTTM="1.062"
ProfitMargin="0"
OperatingMarginTTM="-3.782"
ReturnOnAssetsTTM="-0.266"
ReturnOnEquityTTM="-5.72"
RevenueTTM="98053000"
GrossProfitTTM="-146225000"
DilutedEPSTTM="-4.59"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="3.018"
AnalystTargetPrice="61.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.52"
PriceToBookRatio="31.9"
EVToRevenue="21.97"
EVToEBITDA="-13.92"
Beta="0.752"
num_52WeekHigh="55.8"
num_52WeekLow="32.26"
num_50DayMovingAverage="36.69"
num_200DayMovingAverage="40.19"
SharesOutstanding="95641000"
DividendDate="None"
ExDividendDate="None"
symbol="CYTK"
open="35.32"
high="35.40"
low="34.61"
price="34.93"
volume="628238.00"
latest_trading_day="2023-07-14"
previous_close="35.50"
change="-0.57"
change_percent="-1.6056%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="71"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="29"
Volume_recent_avg="952791"
Change_recent_avg="-0.12"
Delta_recent_avg="1.6"
Variance_recent_avg="0.8"
Change_ratio_recent_avg="-0.36"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="29"
Aroon_momentum_negative="71"
image_negative_thumbnail_id_1="1164"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0198.jpeg"
image_negative_thumbnail_id_2="499"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="991"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_positive_thumbnail_id_2="630"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0078.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
